Attached files
| file | filename |
|---|---|
| EX-32.1 - EX-32.1 - Immunome Inc. | tmb-20200930xex32d1.htm |
| EX-31.2 - EX-31.2 - Immunome Inc. | tmb-20200930xex31d2.htm |
| EX-31.1 - EX-31.1 - Immunome Inc. | tmb-20200930xex31d1.htm |
| EX-10.17 - EX-10.17 - Immunome Inc. | tmb-20200930xex10d17.htm |
| 10-Q - 10-Q - Immunome Inc. | tmb-20200930x10q.htm |
Exhibit 32.2
CERTIFICATION PURSUANT TO
18 U.S.C. SECTION 1350,
AS ADOPTED PURSUANT TO
SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002
In connection with the Quarterly Report on Form 10-Q of Immunome, Inc. (the “Company”) for the fiscal quarter ended September 30, 2020 as filed with the Securities and Exchange Commission on the date hereof (the “Report”), I certify, pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, that:
(1) | the Report fully complies with the requirements of section 13(a) or 15(d) of the Securities Exchange Act of 1934; and |
(2) | the information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company. |
Date: November 16, 2020 | By: | /s/ Richard F. Fitzgerald |
| Name: | Richard F. Fitzgerald |
| Title: | Chief Financial Officer (Principal Financial Officer) |